SCHEMBL30126151

SCHEMBL30126151

Nc1ccc(OCC2CCOC2)c(Cl)c1

nearest known ligand 0.53

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
MCHR1 Q99705 1/20 0.49
XDH P47989 5/20 0.46
SCN9A Q15858 1/20 0.40
IRAK4 Q9NWZ3 2/20 0.39
CNR1 P21554 1/20 0.39
CNR2 P34972 1/20 0.39
DHFR P00374 1/20 0.38
DCPS Q96C86 1/20 0.38
IDH1 O75874 1/20 0.38
ACACB O00763 1/20 0.38
P2RX4 Q99571 1/20 0.37
HTR2C P28335 2/20 0.37
HTR2B P41595 2/20 0.37
GAA P10253 1/20 0.37
MAPT P10636 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
GRM4 Q14833 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30126836 1.00 MCHR1 (0.49) MCHR1XDHSCN9AIRAK4CNR1
SCHEMBL30126942 1.00 MCHR1 (0.49) MCHR1XDHSCN9AIRAK4CNR1
SCHEMBL19089352 0.92 SCN9A (0.46) MCHR1XDHSCN9ADHFRDCPS
SCHEMBL30140430 0.88 HTR2C (0.37) MCHR1XDHIRAK4HTR2CHTR2B
SCHEMBL2562599 0.84 KMO (0.47) HTR2CHTR2B
SCHEMBL30781076 0.84 KMO (0.47) HTR2CHTR2B
SCHEMBL29915641 0.83 MCHR1 (0.49) MCHR1XDHIRAK4DHFRDCPS
SCHEMBL21652826 0.83 MCHR1 (0.49) MCHR1XDHIRAK4DHFRDCPS
SCHEMBL23328015 0.81 HPGD (0.50) MCHR1SCN9AP2RX4HTR2CHTR2B
SCHEMBL30882116 0.81 HPGD (0.50) MCHR1SCN9AP2RX4HTR2CHTR2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022266426-A1 6-(HETEROCYCLOALKYL-OXY)-QUINAZOLINE DERIVATIVES AND USES THEREOF BLACK DIAMOND THERAPEUTICS, INC. (US) 2022-12-22 WO disclosed
WO-2022266458-A1 6-HETEROCYCLOALKYL-QUINAZOLINE DERIVATIVES AND USES THEREOF BLACK DIAMOND THERAPEUTICS, INC. (US) 2022-12-22 WO disclosed